Patient Engagement in Research Scale (PEIRS-22): Danish translation, applicability, and user experiences.

Danish Focus groups PEIRS-22 Patient Engagement in Research Scale Patient and Public Involvement Patient engagement

Journal

Research involvement and engagement
ISSN: 2056-7529
Titre abrégé: Res Involv Engagem
Pays: England
ID NLM: 101708164

Informations de publication

Date de publication:
07 Dec 2023
Historique:
received: 08 08 2023
accepted: 30 11 2023
medline: 8 12 2023
pubmed: 8 12 2023
entrez: 8 12 2023
Statut: epublish

Résumé

Patient and Public Involvement (PPI) in health research is gaining increased attention and acceptance worldwide. Reliable measurements are crucial to accurately assess, monitor, and evaluate patient involvement efforts in research. The Patient Engagement in Research Scale (PEIRS-22) measures meaningful patient and family caregiver engagement in research. This study focuses on three primary objectives: (1) translation of the PEIRS-22 from English to Danish, followed by linguistic validation and cultural adaptation; (2) assessing the applicability of the Danish PEIRS-22; and (3) focus group interviews to explore the user experiences of PPI. A three-phase multi-method study was conducted. In phase one, the PEIRS-22 was translated, linguistically validated and culturally adapted to Danish. In phase two individuals from three distinct patient cancer advisory boards responded to the Danish version of PEIRS-22 to assess its applicability. Three focus group interviews were conducted in phase three, involving individuals from three patient cancer advisory boards. The translation process resulted in a Danish version of PEIRS-22, conceptually and culturally equivalent to the English version. Overall, among individuals of the three advisory boards (n = 15) the applicability was found to be satisfactory, with no missing data and all items completed. The total PEIRS-22 score among the three advisory boards was 85.2 out of a possible 100, with higher scores indicating greater meaningful involvement. A nested sample of the three patient cancer advisory boards (n = 9) participated in focus group interviews. The analysis yielded four themes: (1) The Danish PEIRS-22 captured the intended cultural meaning and contributed to self-reflection, (2) Internal motivation is a driver for involvement (3), Involvement brought a personal sense of empowerment and (4) Meaningful involvement collaborations are fostered by a trustful atmosphere. The PEIRS-22 questionnaire has been translated, linguistically validated, and culturally adapted into Danish. We propose that the PEIRS-22 is now ready for use in Danish populations. This study provides a Danish version of the questionnaire that can be used to develop patient-centred practices and foster meaningful involvement and collaborations between patients and researchers in the field of cancer research in Denmark. Personal benefits of participating in PPI can vary, and we recommend using PEIRS-22 in conjunction with a qualitative approach to better explore perspectives on meaningful involvement. The study was registered prospectively on October 22, 2022, by the Danish Data Protection Agency (jr. nr. P-2022-528). Patient and public involvement (PPI) in research can improve research practices by ensuring that patients' voices are heard. Individuals’ lived experiences and unique viewpoints can contribute to refining research aims, ensuring they align with the needs and priorities of the target population. There is a growing interest in inviting patients into the research team as patient partners, for example, by establishing patient advisory boards. PPI can also involve caregivers and other stakeholders who are not usually thought of as members of the research team. For that reason, broadening our understanding of establishing meaningful PPI starts with measuring patient and family caregiver involvement. As such, the Patient Engagement In Research Scale (PEIRS-22) has been developed in the English language to measure meaningful patient and caregiver involvement. In this study, we aimed to (1) create a Danish version of the PEIRS-22 that respects any unique feature of Danish people, (2) assess the applicability of the Danish PEIRS-22, and (3) via focus-group interviews explore the user experiences of PPI. The patients and caregiver who were interviewed as part of the translation process expressed that the PEIRS-22 was easy to understand and captured the intended meanings. Fifteen other patient partners responded to the Danish version of PEIRS-22, and nine of them participated in the focus group interviews. One result was that creating a trusting and social atmosphere within the research group is important for promoting a personal sense of involvement.

Sections du résumé

BACKGROUND BACKGROUND
Patient and Public Involvement (PPI) in health research is gaining increased attention and acceptance worldwide. Reliable measurements are crucial to accurately assess, monitor, and evaluate patient involvement efforts in research. The Patient Engagement in Research Scale (PEIRS-22) measures meaningful patient and family caregiver engagement in research. This study focuses on three primary objectives: (1) translation of the PEIRS-22 from English to Danish, followed by linguistic validation and cultural adaptation; (2) assessing the applicability of the Danish PEIRS-22; and (3) focus group interviews to explore the user experiences of PPI.
METHODS METHODS
A three-phase multi-method study was conducted. In phase one, the PEIRS-22 was translated, linguistically validated and culturally adapted to Danish. In phase two individuals from three distinct patient cancer advisory boards responded to the Danish version of PEIRS-22 to assess its applicability. Three focus group interviews were conducted in phase three, involving individuals from three patient cancer advisory boards.
RESULTS RESULTS
The translation process resulted in a Danish version of PEIRS-22, conceptually and culturally equivalent to the English version. Overall, among individuals of the three advisory boards (n = 15) the applicability was found to be satisfactory, with no missing data and all items completed. The total PEIRS-22 score among the three advisory boards was 85.2 out of a possible 100, with higher scores indicating greater meaningful involvement. A nested sample of the three patient cancer advisory boards (n = 9) participated in focus group interviews. The analysis yielded four themes: (1) The Danish PEIRS-22 captured the intended cultural meaning and contributed to self-reflection, (2) Internal motivation is a driver for involvement (3), Involvement brought a personal sense of empowerment and (4) Meaningful involvement collaborations are fostered by a trustful atmosphere.
CONCLUSIONS CONCLUSIONS
The PEIRS-22 questionnaire has been translated, linguistically validated, and culturally adapted into Danish. We propose that the PEIRS-22 is now ready for use in Danish populations. This study provides a Danish version of the questionnaire that can be used to develop patient-centred practices and foster meaningful involvement and collaborations between patients and researchers in the field of cancer research in Denmark. Personal benefits of participating in PPI can vary, and we recommend using PEIRS-22 in conjunction with a qualitative approach to better explore perspectives on meaningful involvement.
TRIAL REGISTRATION BACKGROUND
The study was registered prospectively on October 22, 2022, by the Danish Data Protection Agency (jr. nr. P-2022-528).
Patient and public involvement (PPI) in research can improve research practices by ensuring that patients' voices are heard. Individuals’ lived experiences and unique viewpoints can contribute to refining research aims, ensuring they align with the needs and priorities of the target population. There is a growing interest in inviting patients into the research team as patient partners, for example, by establishing patient advisory boards. PPI can also involve caregivers and other stakeholders who are not usually thought of as members of the research team. For that reason, broadening our understanding of establishing meaningful PPI starts with measuring patient and family caregiver involvement. As such, the Patient Engagement In Research Scale (PEIRS-22) has been developed in the English language to measure meaningful patient and caregiver involvement. In this study, we aimed to (1) create a Danish version of the PEIRS-22 that respects any unique feature of Danish people, (2) assess the applicability of the Danish PEIRS-22, and (3) via focus-group interviews explore the user experiences of PPI. The patients and caregiver who were interviewed as part of the translation process expressed that the PEIRS-22 was easy to understand and captured the intended meanings. Fifteen other patient partners responded to the Danish version of PEIRS-22, and nine of them participated in the focus group interviews. One result was that creating a trusting and social atmosphere within the research group is important for promoting a personal sense of involvement.

Autres résumés

Type: plain-language-summary (eng)
Patient and public involvement (PPI) in research can improve research practices by ensuring that patients' voices are heard. Individuals’ lived experiences and unique viewpoints can contribute to refining research aims, ensuring they align with the needs and priorities of the target population. There is a growing interest in inviting patients into the research team as patient partners, for example, by establishing patient advisory boards. PPI can also involve caregivers and other stakeholders who are not usually thought of as members of the research team. For that reason, broadening our understanding of establishing meaningful PPI starts with measuring patient and family caregiver involvement. As such, the Patient Engagement In Research Scale (PEIRS-22) has been developed in the English language to measure meaningful patient and caregiver involvement. In this study, we aimed to (1) create a Danish version of the PEIRS-22 that respects any unique feature of Danish people, (2) assess the applicability of the Danish PEIRS-22, and (3) via focus-group interviews explore the user experiences of PPI. The patients and caregiver who were interviewed as part of the translation process expressed that the PEIRS-22 was easy to understand and captured the intended meanings. Fifteen other patient partners responded to the Danish version of PEIRS-22, and nine of them participated in the focus group interviews. One result was that creating a trusting and social atmosphere within the research group is important for promoting a personal sense of involvement.

Identifiants

pubmed: 38062535
doi: 10.1186/s40900-023-00526-2
pii: 10.1186/s40900-023-00526-2
pmc: PMC10704757
doi:

Types de publication

Journal Article

Langues

eng

Pagination

115

Subventions

Organisme : Novo Nordisk Fonden
ID : 0065353

Informations de copyright

© 2023. The Author(s).

Références

Health Expect. 2019 Aug;22(4):709-720
pubmed: 31379094
Health Expect. 2019 Aug;22(4):785-801
pubmed: 31012259
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Res Involv Engagem. 2022 Aug 26;8(1):43
pubmed: 36028911
Value Health. 2005 Mar-Apr;8(2):94-104
pubmed: 15804318
BMJ. 2017 Aug 2;358:j3453
pubmed: 28768629
BMC Med. 2020 Apr 13;18(1):79
pubmed: 32279658
Health Expect. 2018 Dec;21(6):1075-1084
pubmed: 30062858
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Health Expect. 2019 Feb;22(1):3-20
pubmed: 30378234
J Patient Exp. 2020 Dec;7(6):1610-1620
pubmed: 33457621
Chest. 2022 Feb;161(2):382-388
pubmed: 34740590
Res Involv Engagem. 2022 Jun 6;8(1):24
pubmed: 35668479
Eur J Oncol Nurs. 2023 Jun;64:102351
pubmed: 37290166
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Acta Oncol. 2019 May;58(5):634-641
pubmed: 30724640
J Clin Epidemiol. 2023 Jul;159:49-57
pubmed: 37182587
Health Expect. 2020 Jun;23(3):523-539
pubmed: 32157777
PLoS One. 2018 Nov 1;13(11):e0206588
pubmed: 30383823
Res Involv Engagem. 2022 Oct 3;8(1):55
pubmed: 36192817
Acta Oncol. 2022 May;61(5):602-607
pubmed: 35311443
BMJ Open. 2015 Jul 27;5(7):e007765
pubmed: 26216152
J Med Philos. 2023 Jun 20;48(4):400-412
pubmed: 37229555
Front Psychol. 2020 Jul 24;11:1395
pubmed: 32793022
Health Res Policy Syst. 2023 Jan 25;21(1):12
pubmed: 36698200
Prev Med. 2023 Feb;167:107412
pubmed: 36592674
Res Involv Engagem. 2021 Jul 22;7:53
pubmed: 34294162
Health Res Policy Syst. 2023 Jan 05;21(1):3
pubmed: 36604697
Clin J Am Soc Nephrol. 2022 Feb;17(2):215-227
pubmed: 35131928
Qual Health Res. 2016 Nov;26(13):1753-1760
pubmed: 26613970
Health Expect. 2021 Jun;24(3):863-879
pubmed: 33729634
J Patient Cent Res Rev. 2021 Jan 19;8(1):64-67
pubmed: 33511255
Res Involv Engagem. 2020 Jun 19;6:33
pubmed: 32579132

Auteurs

Mille Guldager Christiansen (MG)

Department of Oncology, Center for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark. mille.guldager.christiansen@regionh.dk.
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. mille.guldager.christiansen@regionh.dk.

Helle Pappot (H)

Department of Oncology, Center for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Clayon Hamilton (C)

BC Mental Health and Substance Use Service at Provincial Health Service Authority, Simon Fraser University, British Columbia, Canada.

Trine Lund-Jacobsen (T)

Department of Endocrinology, Center for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark.

Anne Wilhøft Kristensen (AW)

Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.

Sara Nordentoft (S)

Department of Neurosurgery, Center for Neuroscience, Copenhagen University Hospital, Rigshospitalet, Denmark.

Beverley Lim Høeg (BL)

Psychological Aspects of Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.

Pernille Bidstrup (P)

Psychological Aspects of Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.
Institute of Psychology, University of Copenhagen, Copenhagen, Denmark.

Iben Husted Nielsen (IH)

Department of Hematology, Center for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark.

Jane Ulstrup (J)

, Copenhagen, Denmark.

Anouk Kirsten Trip (AK)

Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.

Mary Jarden (M)

Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Department of Hematology, Center for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark.

Karin Piil (K)

Department of Oncology, Center for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark.
Department of People and Technology, Roskilde University, Roskilde, Denmark.

Classifications MeSH